Overtesting and inadequate management of 25-hydroxyvitamin D status in paediatric secondary and tertiary care
Arch Dis Child
.
2023 Mar;108(3):242-243.
doi: 10.1136/archdischild-2022-325006.
Epub 2022 Dec 29.
Authors
Justin Huw Davies
1
2
,
Molly Handcock
2
,
Paul Cook
3
,
Olivia Kaye
3
,
Rebecca Jane Moon
4
5
Affiliations
1
Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
2
Faculty of Medicine, University of Southampton, Southampton, UK.
3
Clinical Biochemistry, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
4
Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust, Southampton, UK rm@mrc.soton.ac.uk.
5
MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
PMID:
36581394
DOI:
10.1136/archdischild-2022-325006
No abstract available
Keywords:
Biochemistry; Endocrinology; Paediatrics.
Publication types
Letter
MeSH terms
Child
Humans
Tertiary Healthcare
Vitamin D Deficiency* / complications
Vitamin D Deficiency* / diagnosis
Vitamin D*
Substances
25-hydroxyvitamin D
Vitamin D
Grants and funding
MC_UP_A620_1015/MRC_/Medical Research Council/United Kingdom
MC_PC_21003/MRC_/Medical Research Council/United Kingdom
MC_UU_12011/2/MRC_/Medical Research Council/United Kingdom
17702/VAC_/Versus Arthritis/United Kingdom
21231/VAC_/Versus Arthritis/United Kingdom